Masaru Matsuda

2020

In 2020, Masaru Matsuda earned a total compensation of $1.7M as Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary at Halozyme Therapeutics.

Compensation breakdown

Bonus$50,000
Non-Equity Incentive Plan$203,940
Option Awards$500,008
Salary$440,000
Stock Awards$500,019
Other$13,901
Total$1,707,868

Matsuda received $500K in stock awards, accounting for 29% of the total pay in 2020.

Matsuda also received $50K in bonus, $203.9K in non-equity incentive plan, $500K in option awards, $440K in salary and $13.9K in other compensation.

Rankings

In 2020, Masaru Matsuda's compensation ranked 6,262nd out of 13,090 executives tracked by ExecPay. In other words, Matsuda earned more than 52.2% of executives.

ClassificationRankingPercentile
All
6,262
out of 13,090
52nd
Division
Manufacturing
2,579
out of 5,618
54th
Major group
Chemicals And Allied Products
1,038
out of 2,251
54th
Industry group
Drugs
897
out of 1,951
54th
Industry
Biological Products, Except Diagnostic Substances
216
out of 411
47th

Pay ratio

Masaru Matsuda's Pay$1,707,868
Median Employee's Pay$223,441
Pay Ratio

8

to 1

In 2020, the annual total compensation of Masaru Matsuda was $1,707,868.

The annual total compensation of the median employee at Halozyme Therapeutics was $223,441.

The ratio of Masaru Matsuda's pay to the pay of median employee was therefore 8 to one.

Source: SEC filing on March 26, 2021.

Matsuda's colleagues

We found four more compensation records of executives who worked with Masaru Matsuda at Halozyme Therapeutics in 2020.

2020

Helen Torley

Halozyme Therapeutics

Chief Executive Officer

2020

Elaine Sun

Halozyme Therapeutics

Chief Financial Officer

2020

Michael LaBarre

Halozyme Therapeutics

Senior Vice President, Chief Technical Officer

2020

Laurie Stelzer

Halozyme Therapeutics

Chief Financial Officer

News

You may also like